EASE(TM) is a prospective, randomized IDE study comparing automated ESG to manual suturing, advancing Nitinotes toward U.S. regulatory submission CAESAREA, Israel, Dec. 10, 2025 /PRNewswire/ -- ...
Medical Device Network on MSN
First patient treated in Nitinotes’ trial of EndoZip system for ESG
Nitinotes has commenced its US investigational device exemption (IDE) Endoscopic Automated Sleeve Evaluation (EASE) clinical trial, with the first patient treated using the EndoZip automated suturing ...
A new tool, trained on videos of expert surgeons at work, offers students real-time personalized advice as they practice ...
Surgeries with the endoscope are exacting and require special capabilities of the surgeon. The suturing of the tissue and the setting of the knots, in particular, is very complicated due to the lack ...
NORTH HAVEN, Conn.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the worldwide launch of the SILS™ Stitch articulating suturing device for ...
Perineal injuries have been neglected and deprioritised, at the expense of women’s health and wellbeing, write Kathrine ...
LAWRENCE, Kan. Maj. Dimitri M. Thomas, Chief of Surgery and Ltc. Matthew N. Fandre, Deputy Director for Clinical Services, Munson Army Health Center (MAHC), had the opportunity to share the Army ...
The EASE™ Clinical Trial (Endoscopic Automated Sleeve Evaluation) is a prospective, multicenter, randomized, two-arm, blinded IDE study evaluating the safety and effectiveness of the EndoZip™ ...
CAESAREA, Israel, Dec. 10, 2025 /PRNewswire/ -- Nitinotes Ltd., an early commercial stage medical technology company developing fully automated endoluminal suturing solutions for obesity treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback